Ikarian Capital’s Connect Biopharma Holdings CNTB Stock Holding History

Ikarian Capital’s Portfolio CNTB Stock Details CNTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.8M	Sell	4,538,534 -849,952	-16%	-$2.06M	1.16%	25
2026 Q1	$13.1M	Buy	5,388,486 +600,000	+13%	+$1.56M	1.07%	23
2025 Q4	$13.5M	Buy	+4,788,486	New	+$10.2M	1.05%	29
2023 Q3	–	Sell	-219,501	Closed	-$244K	–	156
2023 Q2	$244K	Hold	219,501	–	–	0.04%	109
2023 Q1	$219K	Hold	219,501	–	–	0.05%	105
2022 Q4	$190K	Hold	219,501	–	–	0.05%	73
2022 Q3	$283K	Sell	219,501 -458,358	-68%	-$551K	0.06%	91
2022 Q2	$591K	Hold	677,859	–	–	0.11%	100
2022 Q1	$2.05M	Buy	677,859 +415,622	+158%	+$1.75M	0.27%	69
2021 Q4	$1.35M	Buy	+262,237	New	+$2.91M	0.2%	84

Other funds holding CNTB

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

Richmond Brothers Jackson, Michigan $192M AUM 23.02% 1-Year Est. Return

DMKJ

David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Ikarian Capital's CNTB Position: Q2 2026 in Review

Ikarian Capital reduced its Connect Biopharma Holdings (CNTB) stake by 16% in Q2 2026, selling an estimated $2.06M and leaving 4,538,534 shares worth $10.8M. The position accounts for 1.16% of the portfolio, ranked #25.

Ikarian Capital first reported a position in CNTB in Q4 2021 and has held it in 10 quarters since. The position peaked at $13.5M in Q4 2025. 56 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

Ikarian Capital held 4,538,534 shares of Connect Biopharma Holdings worth $10.8M as of Q2 2026.
Ikarian Capital sold 849,952 Connect Biopharma Holdings shares in Q2 2026, an estimated $2.06M.
Connect Biopharma Holdings made up 1.16% of Ikarian Capital's portfolio in Q2 2026, its #25 holding.
Ikarian Capital first reported a position in Connect Biopharma Holdings in Q4 2021 and has held it in 10 quarters since.
Ikarian Capital's Connect Biopharma Holdings position peaked at $13.5M in Q4 2025.
56 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.